| Integrative clinical genomics of advanced prostate cancer D Robinson, EM Van Allen, YM Wu, N Schultz, RJ Lonigro, JM Mosquera, ... Cell 161 (5), 1215-1228, 2015 | 3841 | 2015 |
| Maintenance of intratumoral androgens in metastatic prostate cancer: a mechanism for castration-resistant tumor growth RB Montgomery, EA Mostaghel, R Vessella, DL Hess, TF Kalhorn, ... Cancer research 68 (11), 4447-4454, 2008 | 1718 | 2008 |
| Androgen deprivation therapy: progress in understanding mechanisms of resistance and optimizing androgen depletion WP Harris, EA Mostaghel, PS Nelson, B Montgomery Nature clinical practice Urology 6 (2), 76-85, 2009 | 1031 | 2009 |
| Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variant S Sun, CCT Sprenger, RL Vessella, K Haugk, K Soriano, EA Mostaghel, ... The Journal of clinical investigation 120 (8), 2715-2730, 2010 | 885 | 2010 |
| Resistance to CYP17A1 inhibition with abiraterone in castration-resistant prostate cancer: induction of steroidogenesis and androgen receptor splice variants EA Mostaghel, BT Marck, SR Plymate, RL Vessella, S Balk, ... Clinical cancer research 17 (18), 5913-5925, 2011 | 700 | 2011 |
| Distinct transcriptional programs mediated by the ligand-dependent full-length androgen receptor and its splice variants in castration-resistant prostate cancer R Hu, C Lu, EA Mostaghel, S Yegnasubramanian, M Gurel, C Tannahill, ... Cancer research 72 (14), 3457-3462, 2012 | 653 | 2012 |
| Androgen receptor pathway-independent prostate cancer is sustained through FGF signaling EG Bluemn, IM Coleman, JM Lucas, RT Coleman, S Hernandez-Lopez, ... Cancer cell 32 (4), 474-489. e6, 2017 | 648 | 2017 |
| Intraprostatic androgens and androgen-regulated gene expression persist after testosterone suppression: therapeutic implications for castration-resistant prostate cancer EA Mostaghel, ST Page, DW Lin, L Fazli, IM Coleman, LD True, ... Cancer research 67 (10), 5033-5041, 2007 | 638 | 2007 |
| Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial LS Marks, NA Mazer, E Mostaghel, DL Hess, FJ Dorey, JI Epstein, ... Jama 296 (19), 2351-2361, 2006 | 533 | 2006 |
| The androgen-regulated protease TMPRSS2 activates a proteolytic cascade involving components of the tumor microenvironment and promotes prostate cancer metastasis JM Lucas, C Heinlein, T Kim, SA Hernandez, MS Malik, LD True, ... Cancer discovery 4 (11), 1310-1325, 2014 | 521 | 2014 |
| Intratumoral De Novo Steroid Synthesis Activates Androgen Receptor in Castration-Resistant Prostate Cancer and Is Upregulated by Treatment with CYP17A1 … C Cai, S Chen, P Ng, GJ Bubley, PS Nelson, EA Mostaghel, B Marck, ... Cancer research 71 (20), 6503-6513, 2011 | 510 | 2011 |
| Mechanisms of the androgen receptor splicing in prostate cancer cells LL Liu, N Xie, S Sun, S Plymate, E Mostaghel, X Dong Oncogene 33 (24), 3140-3150, 2014 | 354 | 2014 |
| Transdifferentiation as a mechanism of treatment resistance in a mouse model of castration-resistant prostate cancer M Zou, R Toivanen, A Mitrofanova, N Floch, S Hayati, Y Sun, ... Cancer discovery 7 (7), 736-749, 2017 | 346 | 2017 |
| A molecular correlate to the Gleason grading system for prostate adenocarcinoma L True, I Coleman, S Hawley, CY Huang, D Gifford, R Coleman, TM Beer, ... Proceedings of the National Academy of Sciences 103 (29), 10991-10996, 2006 | 344 | 2006 |
| Molecular profiling stratifies diverse phenotypes of treatment-refractory metastatic castration-resistant prostate cancer MP Labrecque, IM Coleman, LG Brown, LD True, L Kollath, B Lakely, ... The Journal of clinical investigation 129 (10), 4492-4505, 2019 | 327 | 2019 |
| LuCaP prostate cancer patient‐derived xenografts reflect the molecular heterogeneity of advanced disease and serve as models for evaluating cancer therapeutics HM Nguyen, RL Vessella, C Morrissey, LG Brown, IM Coleman, ... The Prostate 77 (6), 654-671, 2017 | 285 | 2017 |
| Intense androgen-deprivation therapy with abiraterone acetate plus leuprolide acetate in patients with localized high-risk prostate cancer: results of a randomized phase II … ME Taplin, B Montgomery, CJ Logothetis, GJ Bubley, JP Richie, BL Dalkin, ... Journal of clinical oncology 32 (33), 3705-3715, 2014 | 269 | 2014 |
| Persistent intraprostatic androgen concentrations after medical castration in healthy men ST Page, DW Lin, EA Mostaghel, DL Hess, LD True, JK Amory, PS Nelson, ... The Journal of Clinical Endocrinology & Metabolism 91 (10), 3850-3856, 2006 | 264 | 2006 |
| Rapid induction of androgen receptor splice variants by androgen deprivation in prostate cancer Z Yu, S Chen, AG Sowalsky, OS Voznesensky, EA Mostaghel, PS Nelson, ... Clinical cancer research 20 (6), 1590-1600, 2014 | 235 | 2014 |
| Androgen action and metabolism in prostate cancer SM Green, EA Mostaghel, PS Nelson Molecular and cellular endocrinology 360 (1-2), 3-13, 2012 | 223 | 2012 |
